Shows
scientifica sessions.The Frontier Formula: Oklahoma's Blueprint for America's Next Life Sciences HubEpisode DescriptionWhat if the next great American life sciences hub isn’t on the coasts—but in the heartland?In this episode of scientifica sessions, we look beyond the usual biotech strongholds to explore Oklahoma’s emergence as a new life sciences contender. While Boston and San Francisco dominate the narrative, Oklahoma is quietly building a different model—one that blends energy-sector expertise, agricultural biotechnology, and targeted infrastructure investment to create a distinct innovation advantage.Host Tabari Baker is joined by Oklahoma life sci...
2026-02-1647 min
scientifica sessions.From Concept to Capital: How Early-Stage Biotech Gets Funded with Dan GoddardEpisode DescriptionIn this episode of scientifica sessions, host Tabari Baker (Founder & CEO, kronos scientifica) sits down with Dan Goddard, Business Development Lead at CFGO, to explore one of the most critical—and misunderstood—journeys in life sciences: moving a company from concept to capital.Early-stage biotech lives at the intersection of breakthrough science, disciplined execution, and financial reality. When those elements align, companies build durable foundations that survive pivots, funding cycles, and market downturns. When they don’t, even exceptional science can stall...
2026-02-0145 min
scientifica sessions.From Friction to Function: Fixing Collaboration with Patrina Pellett and Chase WassonEpisode DescriptionIn this episode of scientifica sessions, host Tabari Baker (Founder & CEO, kronos scientifica) tackles one of the most persistent—and consequential—tensions in life sciences: the complicated relationship between Medical Affairs and Commercial. Too often it’s a “love–hate” dynamic fueled by shared stakeholders, unclear roles, conflicting metrics, and leadership misalignment. When it works, the field moves in lockstep. When it doesn’t, everyone feels it—especially HCPs.Tabari is joined by two guests who live this challenge from different angles:Patrina Pellett, Co-CEO of MSL Ma...
2026-01-1546 min
Genetics for HealthcareClinical Connectors: MSLs Driving Patient Access in the Genomic EraRome reconnects with Dr Tabari Baker, medical affairs executive and pioneer in the Medical Science Liaison (MSL) role. We learn how MSL have become critical connectors to revolutionize patient access to precision medicine. As genetic and genomic testing, particularly NGS, becomes increasingly central to healthcare, MSLs serve as the vital resource to clinicians, translating complex clinical science into practical applications that directly benefit patients.Discover how Dr. Baker's work and the broader MSL community empower clinicians to interpret and apply the fast-growing title wave of genomic insights, especially as precision medicine expands beyond oncology into areas like...
2025-12-2033 min
scientifica sessions.Genomics, Access, and the Human Story Behind Precision Medicine: A Conversation with Rome MadisonEpisode DescriptionIn this episode of scientifica sessions, we sit down with Rome Madison—founder of the Genetics for Healthcare podcast and a leading voice in genomic sales enablement and clinician education. With more than two decades of experience helping life-science organizations adopt precision medicine, Rome focuses on translating complex genomic science into practical, real-world clinical action.He shares how a family health crisis sparked his career at the dawn of the post–Human Genome Project era. We trace the evolution of precision medicine—from early fresh-tissue assays...
2025-12-1559 min
scientifica sessions.The Dark Side of Data: Power, Privacy, and the Pursuit of Precision with Ardy ArianpourEpisode DescriptionIn this episode of scientifica sessions, we take an unfiltered look at the complex relationship between innovation, privacy, and power in healthcare data with Ardy Arianpour, CEO and Co-Founder of SEQSTER.The life sciences industry is overflowing with data—EHRs, genomic profiles, claims data, wearables, and AI-driven predictions—but more data doesn't always mean better decisions. Together with host Tabari Baker, Ardy explores what happens when the pursuit of precision meets the realities of fragmentation, bias, and inequity.They unpack the hidden challenges behi...
2025-11-1547 min
scientifica sessions.From Wearables to Real-World Evidence: Drew Schiller on the Future of Life SciencesEpisode DescriptionIn this episode of scientifica sessions, we dive into the rapidly evolving world of real-world evidence (RWE) and patient-generated health data (PGHD) with Drew Schiller, Co-Founder and CEO of Validic. As life sciences companies increasingly look beyond traditional clinical trials, Drew shares how data from wearables, remote monitoring devices, and connected health platforms can be used—even by resource-constrained startups—to support medical strategy, evidence generation, and value-based care.The conversation explores how early-stage biotechs and emerging life sciences companies can resp...
2025-10-151h 07
scientifica sessions.scientifica sessions: Welcome to the ConversationIn this inaugural episode, host Tabari Baker, Founder & CEO of kronos scientifica, introduces Scientifica Sessions—a new podcast at the intersection of science, strategy, and commercialization. With over 15 years of leadership experience in medical affairs, clinical development, and biotech commercialization, Tabari has worked with companies navigating late-stage trials, preparing for launch, and building medical organizations ready for global growth. He's seen firsthand that great science alone isn't enough—it takes evidence, strategy, and authentic engagement to bring innovation from concept to clinic. This episode sets the stage for what's to come: candid conversations with scientists, biot...
2025-09-1502 min
scientifica sessions.Generative Chemogenomics & the Future of Drug Discovery: Inside AI‑Driven R&D with Tom NeyarapallyEpisode Description What if you could screen billions of potential therapies—virtually—in the time it takes to brew your morning coffee? In this episode of scientifica sessions, host Tabari Baker sits down with Tom Neyarapally, CEO and co-founder of Archetype Therapeutics, to explore how AI-native biotech is redefining what's possible in early-stage drug discovery. With a background that spans law, business, and executive leadership at companies like Sema4, Tom offers a rare vantage point on how data, machine learning, and strategic insight converge to accelerate breakthroughs in oncology and beyond. Tom breaks down...
2025-09-141h 12
A Tight 45 with Tabari McCoyA Tight 45 with Tabari McCoy - Episode 059 – Soren BakerSome people make history – Soren Baker excels at documenting it ... And now, he's here to make a little history of his own as the latest guest on A Tight 45 with Tabari McCoy!The man behind 3,500+ articles found in outlets such as The New York Times, Los Angeles Times, Chicago Tribune, XXL and The Source, Baker is one of the most prolific journalists in hip-hop history. The former co-host of Open Bar radio with rapper/actor Xzibit on the legendary 93.5 KDAY in Los An...
2021-12-081h 02
Bring It In | The Future of Work, Jobs, and Education#16: Dr. Tabari Baker — Scientific Affairs Manager, Healthcare Leader, and Expert in Cell and Molecular BiologyAlbert Einstein once said “The tool is irrelevant. The skill is in the person who’s using the hammer.”
Ok, Einstein didn’t say that. Those words of wisdom are from our guest today, Dr. Tabari Baker. Tabari is an accomplished scholar and leader in the healthcare industry serving as the Scientific Affairs Manager at Roche Diagnostics Corporation. He received his Ph.D. in Tumor Biology from Georgetown University and is using his education and expertise to help eradicate health disparities and homelessness in Washington, D.C.
Tabari is an intentional, thoughtful leader with the ability...
2020-11-1617 min